Tags

Type your tag names separated by a space and hit enter

Enantioselective organocatalytic reduction of β-trifluoromethyl nitroalkenes: an efficient strategy for the synthesis of chiral β-trifluoromethyl amines.
Chemistry. 2015 Feb 23; 21(9):3589-95.C

Abstract

An efficient organocatalytic stereoselective reduction of β-trifluoromethyl-substituted nitroalkenes, mediated by 3,5-dicarboxylic ester-dihydropyridines (Hantzsch ester type), has been successfully developed. A multifunctional thiourea-based (S)-valine derivative was found to be the catalyst of choice, promoting the reaction in up to 97% ee. The methodology has been applied to a wide variety of substrates, leading to the formation of differently substituted precursors of enantiomerically enriched β-trifluoromethyl amines. The mechanism of the reaction and the mode of action of the metal-free catalytic species were computationally investigated; on the basis of DFT transition-state (TS) analysis, a model of stereoselection was also proposed.

Authors+Show Affiliations

Dipartimento di Chimica, Universita' degli Studi di Milano via Golgi 19, 20133 Milano (Italy), Fax: (+39) 0250314159.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25573847

Citation

Massolo, Elisabetta, et al. "Enantioselective Organocatalytic Reduction of Β-trifluoromethyl Nitroalkenes: an Efficient Strategy for the Synthesis of Chiral Β-trifluoromethyl Amines." Chemistry (Weinheim an Der Bergstrasse, Germany), vol. 21, no. 9, 2015, pp. 3589-95.
Massolo E, Benaglia M, Orlandi M, et al. Enantioselective organocatalytic reduction of β-trifluoromethyl nitroalkenes: an efficient strategy for the synthesis of chiral β-trifluoromethyl amines. Chemistry. 2015;21(9):3589-95.
Massolo, E., Benaglia, M., Orlandi, M., Rossi, S., & Celentano, G. (2015). Enantioselective organocatalytic reduction of β-trifluoromethyl nitroalkenes: an efficient strategy for the synthesis of chiral β-trifluoromethyl amines. Chemistry (Weinheim an Der Bergstrasse, Germany), 21(9), 3589-95. https://doi.org/10.1002/chem.201405730
Massolo E, et al. Enantioselective Organocatalytic Reduction of Β-trifluoromethyl Nitroalkenes: an Efficient Strategy for the Synthesis of Chiral Β-trifluoromethyl Amines. Chemistry. 2015 Feb 23;21(9):3589-95. PubMed PMID: 25573847.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Enantioselective organocatalytic reduction of β-trifluoromethyl nitroalkenes: an efficient strategy for the synthesis of chiral β-trifluoromethyl amines. AU - Massolo,Elisabetta, AU - Benaglia,Maurizio, AU - Orlandi,Manuel, AU - Rossi,Sergio, AU - Celentano,Giuseppe, Y1 - 2015/01/08/ PY - 2014/10/20/received PY - 2015/1/10/entrez PY - 2015/1/13/pubmed PY - 2015/12/15/medline KW - bifunctional catalyst KW - chiral fluorinated amines KW - nitroalkenes KW - reduction KW - trifluoromethyl derivatives SP - 3589 EP - 95 JF - Chemistry (Weinheim an der Bergstrasse, Germany) JO - Chemistry VL - 21 IS - 9 N2 - An efficient organocatalytic stereoselective reduction of β-trifluoromethyl-substituted nitroalkenes, mediated by 3,5-dicarboxylic ester-dihydropyridines (Hantzsch ester type), has been successfully developed. A multifunctional thiourea-based (S)-valine derivative was found to be the catalyst of choice, promoting the reaction in up to 97% ee. The methodology has been applied to a wide variety of substrates, leading to the formation of differently substituted precursors of enantiomerically enriched β-trifluoromethyl amines. The mechanism of the reaction and the mode of action of the metal-free catalytic species were computationally investigated; on the basis of DFT transition-state (TS) analysis, a model of stereoselection was also proposed. SN - 1521-3765 UR - https://www.unboundmedicine.com/medline/citation/25573847/Enantioselective_organocatalytic_reduction_of_β_trifluoromethyl_nitroalkenes:_an_efficient_strategy_for_the_synthesis_of_chiral_β_trifluoromethyl_amines_ DB - PRIME DP - Unbound Medicine ER -